Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2005
03/17/2005WO2005023775A1 Pesticides
03/17/2005WO2005023773A1 Process for the preparation of substituted aryl pyrazoles
03/17/2005WO2005023769A1 Process for the preparation of amlodipine salts
03/17/2005WO2005023762A1 Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
03/17/2005WO2005023760A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/17/2005WO2005023251A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005WO2005023192A2 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/17/2005WO2005007652A3 Substituted quinolin-4-ylamine analogues
03/17/2005WO2005005415A8 Indoles useful in the treatment of inflammation
03/17/2005WO2005003120A3 Metabolites of tricyclic amides useful for inhibition of g-protein function and methods of treatment of proliferative diseases
03/17/2005WO2005000820A3 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists
03/17/2005WO2005000817A3 Diphenylpyridine derivatives, preparation and therapeutic application thereof
03/17/2005WO2004092196A3 Tie-2 modulators and methods of use
03/17/2005WO2004072033A3 Pyrazoles and methods of making and using the same
03/17/2005WO2004056808A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5
03/17/2005WO2003053959A8 Heterocyclylamino carbonyluracils
03/17/2005WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders
03/17/2005WO2003037887A8 Therapeutic isoquinoline compounds
03/17/2005WO2002072571A8 Pyridinyl pyrazoles useful for the treatment of copd
03/17/2005US20050059826 Agonists, antagonists or inverse agonists for brain receptors; anxiolytics, antidepressants; nervous system, sleep and psychological disorders; Down syndrome, cognition activators
03/17/2005US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
03/17/2005US20050059702 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine
03/17/2005US20050059693 Heterocyclic thioester and ketone hair growth compositions and uses
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059678 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes
03/17/2005US20050059676 Cyclic pyrazinoylguanidine sodium channel blockers
03/17/2005US20050059675 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia
03/17/2005US20050059672 tricyclic compounds such as 4-{8-Chloro-6-[[(1-methoxy-cyclopropanecarbonyl)-amino]-(3-methyl-3H-imidazol-4- yl)-methyl]-11H-benzo[5.6]cyclohepta[1,2-b]pyridin-11-yl}-piperazine-1-carboxylic acid isopropyl ester, used as enzyme inhibitors for treatment of cancers
03/17/2005US20050059671 Hydroxyiminopiperazine compound for therapy and prophylaxis of Urinary incontinence, Inflammatory-bowel disease, addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder
03/17/2005US20050059669 M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity
03/17/2005US20050059666 CCR5 antagonists useful for treating AIDS
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005US20050059662 Substituted quinazolinone compounds
03/17/2005US20050059652 Open chain prolyl urea-related modulators of androgen receptor function
03/17/2005CA2741575A1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/17/2005CA2741412A1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/17/2005CA2549465A1 New salts of omeprazole and esomeprazole i
03/17/2005CA2537883A1 Substituted bicyclic quinazolin-4-ylamine derivatives
03/17/2005CA2537677A1 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/17/2005CA2537098A1 N3 alkylated benzimidazole derivatives as mek inhibitors
03/17/2005CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/17/2005CA2535983A1 New salts of omeprazole and esomeprazole ii
03/16/2005EP1514870A1 Prodrug and process for producing the same
03/16/2005EP1514867A2 Substituted phenyl derivatives, their preparation and use
03/16/2005EP1514559A1 Arylpiperazines having activity at the serotonin 1a receptor
03/16/2005EP1514115A2 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
03/16/2005EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513832A2 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
03/16/2005EP1513831A1 Novel compounds, their use and preparation
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513829A2 Nicotinoyl derivatives as herbicidal compounds
03/16/2005EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513826A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
03/16/2005EP1513821A1 Protein kinase inhibitors
03/16/2005EP1513820A2 Compounds, compositions, and methods
03/16/2005EP1513817A1 1, 2-azole derivatives with hypoglycemic and hypolipidemic activity
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513812A1 Substituted indoles
03/16/2005EP1513811A1 Non-peptidic brs-3 agonists
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513809A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
03/16/2005EP1513807A1 Pharmaceutical combination
03/16/2005EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
03/16/2005EP1513530A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
03/16/2005EP1513527A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1399436B1 Oxytocin agonists
03/16/2005EP1355903B1 Pyrazole derivatives against tgf overexpression
03/16/2005EP1250047B1 Herbicidal composition
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1226119B1 Tyrosine kinase inhibitors
03/16/2005EP1140900B1 Pyrazole compounds and uses thereof
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1596113A Method of treating depression with delta receptor agonist compounds
03/16/2005CN1594320A Process for preparing L-ofloxacin and ofloxacin
03/16/2005CN1594314A Fluorene based water soluble conjugated polymer and process for preparing same
03/16/2005CN1193027C Substituted pyrroles
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193024C Process for producing optically active sulfoxide devivative'
03/16/2005CA2480218A1 New derivatives of benzoindoline, preparation thereof, and pharmaceutical compounds containing them
03/15/2005US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them
1 ... 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 ... 1080